Cargando…
A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders
BACKGROUND: Maternal depression and anxiety during pregnancy may enhance fetal exposure to glucocorticoids (GCs) and harm neurodevelopment. We tested whether a novel cross-tissue polyepigenetic biomarker indicative of in utero exposure to GC is associated with mental and behavioral disorders and the...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739178/ https://www.ncbi.nlm.nih.gov/pubmed/33344728 http://dx.doi.org/10.1016/j.ynstr.2020.100275 |
_version_ | 1783623277957087232 |
---|---|
author | Suarez, Anna Lahti, Jari Lahti-Pulkkinen, Marius Girchenko, Polina Czamara, Darina Arloth, Janine Malmberg, Anni LK. Hämäläinen, Esa Kajantie, Eero Laivuori, Hannele Villa, Pia M. Reynolds, Rebecca M. Provençal, Nadine Binder, Elisabeth B. Räikkönen, Katri |
author_facet | Suarez, Anna Lahti, Jari Lahti-Pulkkinen, Marius Girchenko, Polina Czamara, Darina Arloth, Janine Malmberg, Anni LK. Hämäläinen, Esa Kajantie, Eero Laivuori, Hannele Villa, Pia M. Reynolds, Rebecca M. Provençal, Nadine Binder, Elisabeth B. Räikkönen, Katri |
author_sort | Suarez, Anna |
collection | PubMed |
description | BACKGROUND: Maternal depression and anxiety during pregnancy may enhance fetal exposure to glucocorticoids (GCs) and harm neurodevelopment. We tested whether a novel cross-tissue polyepigenetic biomarker indicative of in utero exposure to GC is associated with mental and behavioral disorders and their severity in children, possibly mediating the associations between maternal prenatal depressive and anxiety symptoms and these child outcomes. METHODS: Children (n = 814) from the Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study were followed-up from birth to age 7.1–10.7 years. A weighted polyepigenetic GC exposure score was calculated based on the methylation profile of 24 CpGs from umbilical cord blood. Child diagnosis of mental and behavioral disorder (n = 99) and its severity, defined as the number of days the child had received treatment (all 99 had received outpatient treatment and 8 had been additionally in inpatient treatment) for mental or behavioral disorder as the primary diagnosis, came from the Care Register for Health Care. Mothers (n = 408) reported on child total behavior problems at child's age of 2.3–5.8 years and their own depressive and anxiety symptoms during pregnancy (n = 583). RESULTS: The fetal polyepigenetic GC exposure score at birth was not associated with child hazard of mental and behavioral disorder (HR = 0.82, 95% CI 0.54; 1.24, p = 0.35) or total behavior problems (unstandardized beta = −0.10, 95% CI -0.31; 0.10, p = 0.33). However, for one standard deviation decrease in the polyepigenetic score, the child had spent 2.94 (95%CI 1.59; 5.45, p < 0.001) more days in inpatient or outpatient treatment with any mental and behavioral disorder as the primary diagnosis. Criteria for mediation tests were not met. CONCLUSIONS: These findings suggest that fetal polyepigenetic GC exposure score at birth was not associated with any mental or behavioral disorder diagnosis or mother-rated total behavior problems, but it may contribute to identifying children at birth who are at risk for more severe mental or behavioral disorders. |
format | Online Article Text |
id | pubmed-7739178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-77391782020-12-18 A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders Suarez, Anna Lahti, Jari Lahti-Pulkkinen, Marius Girchenko, Polina Czamara, Darina Arloth, Janine Malmberg, Anni LK. Hämäläinen, Esa Kajantie, Eero Laivuori, Hannele Villa, Pia M. Reynolds, Rebecca M. Provençal, Nadine Binder, Elisabeth B. Räikkönen, Katri Neurobiol Stress Original Research Article BACKGROUND: Maternal depression and anxiety during pregnancy may enhance fetal exposure to glucocorticoids (GCs) and harm neurodevelopment. We tested whether a novel cross-tissue polyepigenetic biomarker indicative of in utero exposure to GC is associated with mental and behavioral disorders and their severity in children, possibly mediating the associations between maternal prenatal depressive and anxiety symptoms and these child outcomes. METHODS: Children (n = 814) from the Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study were followed-up from birth to age 7.1–10.7 years. A weighted polyepigenetic GC exposure score was calculated based on the methylation profile of 24 CpGs from umbilical cord blood. Child diagnosis of mental and behavioral disorder (n = 99) and its severity, defined as the number of days the child had received treatment (all 99 had received outpatient treatment and 8 had been additionally in inpatient treatment) for mental or behavioral disorder as the primary diagnosis, came from the Care Register for Health Care. Mothers (n = 408) reported on child total behavior problems at child's age of 2.3–5.8 years and their own depressive and anxiety symptoms during pregnancy (n = 583). RESULTS: The fetal polyepigenetic GC exposure score at birth was not associated with child hazard of mental and behavioral disorder (HR = 0.82, 95% CI 0.54; 1.24, p = 0.35) or total behavior problems (unstandardized beta = −0.10, 95% CI -0.31; 0.10, p = 0.33). However, for one standard deviation decrease in the polyepigenetic score, the child had spent 2.94 (95%CI 1.59; 5.45, p < 0.001) more days in inpatient or outpatient treatment with any mental and behavioral disorder as the primary diagnosis. Criteria for mediation tests were not met. CONCLUSIONS: These findings suggest that fetal polyepigenetic GC exposure score at birth was not associated with any mental or behavioral disorder diagnosis or mother-rated total behavior problems, but it may contribute to identifying children at birth who are at risk for more severe mental or behavioral disorders. Elsevier 2020-11-21 /pmc/articles/PMC7739178/ /pubmed/33344728 http://dx.doi.org/10.1016/j.ynstr.2020.100275 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Article Suarez, Anna Lahti, Jari Lahti-Pulkkinen, Marius Girchenko, Polina Czamara, Darina Arloth, Janine Malmberg, Anni LK. Hämäläinen, Esa Kajantie, Eero Laivuori, Hannele Villa, Pia M. Reynolds, Rebecca M. Provençal, Nadine Binder, Elisabeth B. Räikkönen, Katri A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders |
title | A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders |
title_full | A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders |
title_fullStr | A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders |
title_full_unstemmed | A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders |
title_short | A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders |
title_sort | polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739178/ https://www.ncbi.nlm.nih.gov/pubmed/33344728 http://dx.doi.org/10.1016/j.ynstr.2020.100275 |
work_keys_str_mv | AT suarezanna apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT lahtijari apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT lahtipulkkinenmarius apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT girchenkopolina apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT czamaradarina apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT arlothjanine apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT malmbergannilk apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT hamalainenesa apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT kajantieeero apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT laivuorihannele apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT villapiam apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT reynoldsrebeccam apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT provencalnadine apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT binderelisabethb apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT raikkonenkatri apolyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT suarezanna polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT lahtijari polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT lahtipulkkinenmarius polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT girchenkopolina polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT czamaradarina polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT arlothjanine polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT malmbergannilk polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT hamalainenesa polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT kajantieeero polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT laivuorihannele polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT villapiam polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT reynoldsrebeccam polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT provencalnadine polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT binderelisabethb polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders AT raikkonenkatri polyepigeneticglucocorticoidexposurescoreatbirthandchildhoodmentalandbehavioraldisorders |